Neoadjuvant chemoradiotherapy for locally advanced pancreas cancer rarely leads to radiological evidence of tumour regression

Neo‐adjuvant treatment does not induce radiological tumour regression of LAPC with major vascular involvement. Patient selection for neo‐adjuvant trial enrolment should remain focused on borderline disease which may have a potential for surgical resection.